UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5751
Arbutus Biopharma
ABUS
$915M
| $172K | ﹤0.01% |
55,665
-79,158
| -59% | -$237K |
|
5752
Amplify Lithium & Battery Technology ETF
BATT
$124M
| $171K | ﹤0.01% |
19,504
-5,259
| -21% | -$48.7K |
|
5753
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$265M
| $171K | ﹤0.01% |
12,029
-3,634
| -23% | -$50.1K |
|
5754
James Hardie Industries
JHX
$17.5B
| $171K | ﹤0.01% |
5,420
-11,799
| -69% | -$406K |
|
5755
Horizon Technology Finance
HRZN
$311M
| $171K | ﹤0.01% |
14,178
-2,045
| -13% | -$23.8K |
|
5756
Evolv Technologies
EVLV
$1.1B
| $171K | ﹤0.01% |
66,906
-72,453
| -52% | -$240K |
|
5757
LCNB Corp
LCNB
$283M
| $171K | ﹤0.01% |
12,263
-8,219
| -40% | -$118K |
|
5758
Kovitz Core Equity ETF
EQTY
$1.47B
| $170K | ﹤0.01% |
7,869
+6,791
| +630% | +$146K |
|
5759
Planet Labs
PL
$8.53B
| $170K | ﹤0.01% |
91,599
-127,403
| -58% | -$244K |
|
5760
FRP Holdings
FRPH
$421M
| $170K | ﹤0.01% |
5,956
-9,696
| -62% | -$290K |
|
|
RVPH
5761
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $170K | ﹤0.01% |
6,622
+6,217
| +1,535% | +$283K |
|
5762
SIGA Technologies
SIGA
$219M
| $169K | ﹤0.01% |
22,307
-42,583
| -66% | -$347K |
|
5763
Kura Sushi USA
KRUS
$593M
| $169K | ﹤0.01% |
2,680
-4,074
| -60% | -$411K |
|
5764
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
| $169K | ﹤0.01% |
2,586
+931
| +56% | +$61.6K |
|
5765
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.4M
| $169K | ﹤0.01% |
3,216
-1,227
| -28% | -$64.3K |
|
5766
Full House Resorts
FLL
$89M
| $169K | ﹤0.01% |
33,802
+392
| +1% | +$1.99K |
|
5767
South Plains Financial
SPFI
$841M
| $169K | ﹤0.01% |
6,248
-6,905
| -52% | -$182K |
|
5768
AllianzIM U.S. Equity Buffer10 Aug ETF
AUGT
$30.4M
| $169K | ﹤0.01% |
5,803
+5,697
| +5,375% | +$160K |
|
5769
Actinium Pharmaceuticals
ATNM
$25M
| $169K | ﹤0.01% |
22,774
-4,942
| -18% | -$40.7K |
|
5770
QuinStreet
QNST
$1.21B
| $168K | ﹤0.01% |
10,149
-28,910
| -74% | -$501K |
|
5771
iHeartMedia
IHRT
$583M
| $168K | ﹤0.01% |
153,877
+32,126
| +26% | +$50K |
|
5772
Silvercrest Asset Management
SAMG
$79.9M
| $168K | ﹤0.01% |
10,752
-5,626
| -34% | -$84.7K |
|
5773
Vanguard US Quality Factor ETF
VFQY
$493M
| $167K | ﹤0.01% |
1,248
-187
| -13% | -$24.9K |
|
|
KFVG
5774
DELISTED
KraneShares CICC China 5G and Semiconductor Index ETF
KFVG
| $167K | ﹤0.01% |
10,782
-564
| -5% | -$8.45K |
|
|
BON
5775
Bon Natural Life
BON
$8.7M
| $167K | ﹤0.01% |
2,758
+2,757
| +275,700% | +$213K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.